A

AQST

AQST

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
AQST Live QuoteReal-time
$3.71
$0.38(-9.19%)1M
Day Range$3.67 – $3.87
Open$3.78
Previous Close$3.78
Volume1.44M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$465.67M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-0.65
Price to Book14.2
Dividend Yield0.65%
Beta (Volatility)1.50
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $3.71 (20%)
Low: $2.93High: $6.74
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$9.33-93.8% upside

Insider Buys

0

$0

Insider Sales

24

$4.09M

Total Volume

$4.09M

38 transactions

Net Activity

$4.09M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
25CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
B
1

Barber Daniel

Pres, CEO

0 buys9 sells

$1.88M total

J
2

Jung Cassie

COO

0 buys4 sells

$976K total

B
3

Boyd Peter E.

Chief People Officer

0 buys4 sells

$337K total

T
4

Toth A Ernest Jr

CFO

0 buys1 sells

$243K total

B
5

Braender Lori J

GC

0 buys1 sells

$167K total

Trading History
AQST insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 15, 2026

1 months ago

Barber Daniel

Pres, CEO

CEO
Sell25.0K$4.22$106K

Sep 15, 2026

2 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell652.3K$-25000.00$0

Sep 15, 2026

2 months ago

Barber Daniel

Pres, CEO

CEO
Sell25.0K$4.82$120K

Sep 9, 2026

2 months ago

Korczynski Sherry

Chief Commercial Officer

C-Level
Sell8.8K$5.22$46K

Sep 9, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell235.7K$-8750.00$0

Aug 17, 2026

3 months ago

Barber Daniel

Pres, CEO

CEO
Sell25.0K$4.29$107K

Aug 17, 2026

3 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell585.6K$-25000.00$0

Jul 15, 2026

4 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell610.6K$-25000.00$0

Jul 15, 2026

4 months ago

Barber Daniel

Pres, CEO

CEO
Sell25.0K$4.01$100K

Jun 23, 2026

5 months ago

Krop Julie

Dir

Director
Sell25.0K$5.02$125K

Jun 23, 2026

5 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell0$-25000.00$0

Jun 15, 2026

5 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell635.6K$-25000.00$0

Jun 15, 2026

5 months ago

Barber Daniel

Pres, CEO

CEO
Sell25.0K$4.16$104K

May 15, 2026

6 months ago

Barber Daniel

Pres, CEO

CEO
Sell8.3K$4.29$35K

May 15, 2026

6 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell660.6K$-8257.00$0

Mar 10, 2026

8 months ago

Cioffi Melina

SVP, Regulatory Affairs

SVP
Sell25.3K$4.17$106K

Mar 10, 2026

8 months ago

Jung Cassie

COO

COO
Sell45.8K$4.17$191K

Mar 10, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell338.5K$-29814.00$0

Mar 10, 2026

8 months ago

Barber Daniel

Pres, CEO

CEO
Sell180.7K$4.17$754K

Mar 10, 2026

8 months ago

Boyd Peter E.

Chief People Officer

C-Level
Sell29.8K$4.17$124K

Mar 10, 2026

8 months ago

Braender Lori J

GC

General Counsel
Sell40.1K$4.17$167K

Mar 10, 2026

8 months ago

Korczynski Sherry

Chief Commercial Officer

C-Level
Sell15.7K$4.17$66K

Mar 10, 2026

8 months ago

Toth A Ernest Jr

CFO

CFO
Sell58.3K$4.17$243K

Oct 15, 2025

13 months ago

Boyd Peter E.

See Remarks

Insider
Sell10.0K$7.00$70K

Oct 15, 2025

13 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell242.8K$-67575.00$0

Oct 15, 2025

13 months ago

Jung Cassie

COO

COO
Sell67.6K$7.01$474K

Oct 15, 2025

13 months ago

Kraus Carl N

Chief Medical Officer

C-Level
Sell20.3K$7.00$142K

Sep 26, 2025

14 months ago

Boyd Peter E.

See Remarks

Insider
Sell10.0K$6.30$63K

Sep 26, 2025

14 months ago

Barber Daniel

Pres, CEO

CEO
Sell91.3K$6.03$551K

Sep 26, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell923.4K$-91343.00$0

Sep 19, 2025

14 months ago

Barber Daniel

Pres, CEO

CEO
Sell400$6.00$2K

Sep 19, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.01M$-400.00$0

Sep 4, 2025

14 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell285.3K$-62180.00$0

Sep 5, 2025

14 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell288.3K$-15000.00$0

Sep 4, 2025

14 months ago

Jung Cassie

COO

COO
Sell62.2K$5.00$311K

Sep 5, 2025

14 months ago

Boyd Peter E.

See Remarks

Insider
Sell15.0K$5.30$80K

Nov 26, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell235.1K$-44.00$0

Nov 26, 2024

24 months ago

Jung Cassie

COO

COO
Sell44$4.87$214
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
AQST Buy Conviction0%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.52B

AQST has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for AQST

Over the last 90 days, corporate insiders at AQST (AQST) engaged in a total of 38 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 24 were sales. The total volume of insider trading reached $4.09M.

The net insider activity for AQST shows a net selling bias of $4.09M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Barber Daniel (Pres, CEO), who traded 180.7K shares valued at $754K on Mar 10, 2026.

Live Market News & Developments
Aggregated real-time headlines for AQST (AQST)
6 updates

Aquestive Therapeutics (AQST): Second Chance At Anaphylm Comes Into Focus

Yahoo Finance74d ago

Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success (NASDAQ:AQST)

Seeking Alpha51d ago

AQST Forecast — Price Target — Prediction for 2027

TradingView147d ago

AQST: Aquestive Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

Quantisnow4d ago

Aquestive Therapeutics, Inc. (AQST) Investor Alert: Possible False Statements After 37% Stock Drop

Schubert Jonckheer & Kolbe45d ago

AQST - Aquestive Therapeutics Inc Stock Price and Quote

Finviz176d ago

FAQs About AQST Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for AQST.

Based on SEC Form 4 disclosures, the Insider Confidence Score for AQST is currently 25/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 24 sales by company executives over the last 90 days.

The CEO Conviction Index for AQST is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.